Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Venance

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
British Journal of Pharmacology|October 10, 2014
Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmissionS G Ferreira, F Q Gonçalves, J M Marques, et al.
Brain : a Journal of Neurology|June 18, 2013
Non-dystrophic myotonia: prospective study of objective and patient reported outcomesJaya R Trivedi, Brian Bundy, Jeffrey Statland, et al.
JAMA|October 4, 2012
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trialJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.
Muscle & Nerve|September 19, 2012
A quantitative measure of handgrip myotonia in non-dystrophic myotoniaJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.
Neurology|October 27, 2010
Clinical features of facioscapulohumeral muscular dystrophy 2J C de Greef, R J L F Lemmers, P Camaño, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
The CNDR: collaborating to translate new therapies for CanadiansLawrence Korngut, Craig Campbell, Megan Johnston, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
British Journal of Pharmacology|October 10, 2014
Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmissionS G Ferreira, F Q Gonçalves, J M Marques, et al.
Brain : a Journal of Neurology|June 18, 2013
Non-dystrophic myotonia: prospective study of objective and patient reported outcomesJaya R Trivedi, Brian Bundy, Jeffrey Statland, et al.
JAMA|October 4, 2012
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trialJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.
Muscle & Nerve|September 19, 2012
A quantitative measure of handgrip myotonia in non-dystrophic myotoniaJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.
Neurology|October 27, 2010
Clinical features of facioscapulohumeral muscular dystrophy 2J C de Greef, R J L F Lemmers, P Camaño, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
The CNDR: collaborating to translate new therapies for CanadiansLawrence Korngut, Craig Campbell, Megan Johnston, et al.
Pageof 7